SEC Filings TLDR

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process 8-K, 6-K, Schedule 13G. We will support more forms in the future.

2025-07-31TIMB6-KTIM S.A. Form 6-K FilingLOW
TIM S.A., a foreign private issuer, filed a Form 6-K with the U.S. Securities and Exchange Commission on July 30, 2025. The filing indicates that the company will file annual reports under Form 20-F. The report was signed by Alberto Mario Griselli, who serves as the Chief Executive Officer, Chief Financial Officer, and...
2025-07-31TIMB6-KTIM S.A. Form 6-K FilingLOW
TIM S.A., a foreign private issuer, filed a Form 6-K with the U.S. Securities and Exchange Commission on July 30, 2025. The filing was submitted electronically and does not include any additional documents or exhibits. The report was signed by Alberto Mario Griselli, who serves as the Chief Executive Officer, Chief Fin...
2025-07-31TIMB6-KTIM S.A. Board of Directors Meeting Minutes - July 30, 2025MEDIUM
The Board of Directors of TIM S.A. held a meeting on July 30, 2025, at the company's headquarters in Rio de Janeiro. The meeting was attended by key members of the board, including Chairman Nicandro Durante and Secretary Fabiane Reschke. The agenda included acknowledging the activities of various committees such as the...
2025-07-31TIMB6-KElection of New Investor Relations Officer at TIM S.A.MEDIUM
TIM S.A. (B3: TIMS3; NYSE: TIMB) announced the election of Mr. Vicente de Moraes Ferreira as the new Investor Relations Officer (DRI), effective August 1, 2025. Mr. Ferreira, who holds a degree in electronics and computer engineering from the Federal University of Rio de Janeiro, an MBA from Fundação Getúlio Vargas, an...
2025-07-31TIMB6-KTIM S.A. Fiscal Council Meeting Minutes - July 30, 2025MEDIUM
The Fiscal Council of TIM S.A. held a meeting on July 30, 2025, at the company's head office in Rio de Janeiro. The meeting was attended by the regular members of the Fiscal Council, the Secretary, and the Chairman of the Board of Directors. The agenda included presentations on the company's tax, regulatory, civil, and...
2025-07-31TAL6-KTAL Education Group Q1 Fiscal 2026 Financial ResultsHIGH
TAL Education Group (NYSE: TAL) announced its unaudited financial results for the first quarter of fiscal year 2026, ended May 31, 2025. The company reported net revenues of $575.0 million, a 38.8% increase from $414.2 million in the same period last year. Income from operations was $14.3 million, compared to a loss of...
2025-07-31TAK6-KInadvertent Disclosure of Oveporexton (TAK-861) AbstractMEDIUM
Takeda Pharmaceutical Company Limited reported an inadvertent disclosure of an abstract related to their Phase 3 TAK-861-3002 study of oveporexton (TAK-861) for narcolepsy type 1. The abstract, which was slated for presentation at the World Sleep 2025 congress, was mistakenly published on the World Sleep Congress websi...
2025-07-31SQNS6-KSequans Communications Preliminary Q2 2025 Financial ResultsMEDIUM
Sequans Communications S.A. (NYSE: SQNS) announced its preliminary financial results for the second quarter ended June 30, 2025. The company reported revenue of $8.1 million, a 1.1% increase from the previous quarter but a 15.8% decrease year-over-year. Gross margin stood at 64.4%, slightly down from 64.5% in Q1 2025 a...
2025-07-31SNY6-KSanofi's Sarclisa Approved in the EU for Multiple Myeloma TreatmentHIGH
In July 2025, Sanofi announced that its drug Sarclisa (isatuximab) has been approved by the European Commission for the treatment of transplant-eligible newly diagnosed multiple myeloma (NDMM). This approval is based on the GMMG-HD7 phase 3 study, which demonstrated that Sarclisa, in combination with bortezomib, lenali...
2025-07-31SNY6-KSanofi 2025 Half-Year Financial ReportHIGH
Sanofi's 2025 half-year financial report highlights the company's financial performance for the first six months of the year. The report includes condensed consolidated financial statements, which show a net income of €5.8 billion, a significant increase from €2.3 billion in the same period of 2024. The company's net s...
2025-07-31SNY6-KSanofi Q2 2025 Financial and Operational HighlightsHIGH
Sanofi reported strong Q2 2025 results with a 10.1% increase in sales at constant exchange rates (CER), driven by key products like Dupixent, which saw a 21.1% growth in sales. The company achieved a business EPS of €1.59, up 8.3% at CER. Sanofi also made significant progress in its pipeline, with three regulatory appr...
2025-07-31SMFG6-KSumitomo Mitsui Financial Group Q1 2025 Financial ResultsMEDIUM
Sumitomo Mitsui Financial Group, Inc. (SMFG) reported its consolidated financial results for the three months ended June 30, 2025. The company's ordinary income decreased by 3.1% to ¥2,444,404 million compared to the same period in 2024. Ordinary profit also declined by 7.2% to ¥483,337 million, while profit attributab...
2025-07-31SIMO6-KSilicon Motion Q2 2025 Financial ResultsMEDIUM
Silicon Motion Technology Corporation announced its financial results for the second quarter of 2025. The company reported a 19% quarter-over-quarter increase in net sales to $198.7 million, though this represented a 6% year-over-year decline. GAAP net income decreased to $16.3 million, or $0.49 per diluted ADS, compar...
2025-07-31SIM6-KGrupo Simec Reports Financial Results for First Half of 2025MEDIUM
Grupo Simec, S.A.B. de C.V. announced its financial results for the first six months of 2025, ending June 30, 2025. The company reported a 9% decrease in net sales, primarily due to an 11% decline in shipments of finished steel products, despite a 3% increase in average sales prices. Net sales dropped from Ps. 16,279 m...
2025-07-31SID6-KCompanhia Siderúrgica Nacional Sells Shares in UsiminasMEDIUM
Companhia Siderúrgica Nacional (CSN) has announced the sale of 35,192,508 common shares and 27,336,139 preferred shares in Usinas Siderúrgicas de Minas Gerais S.A. (Usiminas) to Globe Investimentos S.A. The transaction was executed at the closing price of July 29, 2025. As a result, CSN's stake in Usiminas has been red...
2025-07-31SHEL6-KShell plc Q2 2025 Financial ResultsHIGH
Shell plc released its unaudited condensed interim financial report for the second quarter of 2025. The report highlights a decrease in income attributable to Shell plc shareholders to $3.6 billion, down from $4.8 billion in the previous quarter. Adjusted earnings were $4.3 billion, a 30% decrease compared to the same ...
2025-07-31SHEL6-KShell plc Q2 2025 Interim Dividend and Share Buyback AnnouncementHIGH
Shell plc announced an interim dividend of US$ 0.358 per ordinary share for the second quarter of 2025. Shareholders can elect to receive dividends in US dollars, euros, or pounds sterling. The dividend timetable includes key dates such as the ex-dividend date for ADSs on August 15, 2025, and the payment date on Septem...
2025-07-31SAN6-KSantander SEC Filing Summary for Q2 2025HIGH
The SEC filing for Santander for the second quarter of 2025 provides a comprehensive overview of the company's financial and operational performance. Key highlights include detailed information on financial assets, liabilities, and equity instruments. The filing also covers significant legal proceedings, tax provisions...
2025-07-31SAN6-KBanco Santander S.A. Half-Year Financial Report 2025HIGH
Banco Santander S.A. reported its half-year financial results for 2025, highlighting significant events and financial performance. The bank announced a strategic agreement with Erste Group Bank AG to sell approximately 49% of its stake in Santander Bank Polska S.A. and 50% of the asset management company (TFI) for EUR ...
2025-07-31RTO6-KRentokil Initial plc 2025 Interim ResultsMEDIUM
Rentokil Initial plc reported its 2025 interim results, showing a 3.1% increase in Group Revenue to $3,364 million, with Organic Revenue growth of 1.6%. The North America segment saw a 2.0% revenue increase, while the International business grew by 5.1%. Adjusted Operating Profit decreased by 4.5% to $511 million, prim...
2025-07-31QSG6-KQuantaSing Group Limited Announces Further Investments into LetsvanMEDIUM
QuantaSing Group Limited (NASDAQ: QSG) announced on July 31, 2025, that it will acquire all remaining equity interests in Shenzhen Yiqi Culture Co., Ltd. (Letsvan) through a combination of cash and stock. This transaction follows a series of investments made from December 2024 to March 31, 2025, which allowed QuantaSin...
2025-07-31PUK6-KPrudential plc Total Voting Rights and Issued Share Capital UpdateMEDIUM
Prudential plc, a life and health insurance and asset management company operating in 24 markets across Asia and Africa, has reported its total voting rights and issued share capital as of 31 July 2025. The company's issued share capital consists of 2,578,347,486 ordinary shares of GBP 0.05 each, each carrying one vote...
2025-07-31PUK6-KSettlement Reached in Malaysian Dividend DisputeMEDIUM
Prudential plc has reached a full and final settlement with Detik Ria Sdn Bhd regarding a dividend claim. Detik Ria, a 49% shareholder in Sri Han Suria Sdn Bhd (SHS), had initiated legal proceedings against Prudential in April 2025 concerning dividends amounting to approximately USD$ 833 million plus interest. As part ...
2025-07-31PUK6-KPrudential PLC Share Repurchase AnnouncementMEDIUM
Prudential plc announced the repurchase of 316,056 of its ordinary shares from Merrill Lynch International on 30 July 2025. The shares were purchased at an average price of £9.3851 per share, with the lowest and highest prices paid being £9.3500 and £9.4600, respectively. The repurchase was conducted under the authorit...
2025-07-31PKX6-KPOSCO Holdings Q2 2025 Earnings ReportMEDIUM
POSCO Holdings Inc. reported its Q2 2025 earnings, showing a revenue of KRW 17.56 trillion, a slight increase of 0.7% compared to Q1 2025 but a decrease of 5.1% compared to Q2 2024. Operating profit was KRW 0.61 trillion, up 7.0% from Q1 2025 but down 18.7% from Q2 2024. Profit before income tax was KRW 0.23 trillion, ...